Application segmentation of the GC‑MS Software market delineates five primary end‑use domains: environmental analysis, pharmaceutical/drug discovery, food safety, forensic analysis, and clinical research. Environmental analysis, accounting for roughly 25 % of market revenue, drives demand for high‑throughput pollutant screening and regulatory compliance modules. The pharmaceutical sector, the largest contributor at about 30 %, requires sophisticated deconvolution algorithms and kinetic modeling to support compound identification during drug development. Food safety, representing ~20 %, emphasizes rapid pathogen detection and residue quantification, influencing software design toward real‑time reporting. Forensic analysis, with a 15 % share, prioritizes chain‑of‑custody audit trails and evidentiary data integrity, shaping security features. Clinical research, the smallest slice at 10 %, focuses on biomarker validation and patient‑centric data integration. Collectively, these application segments define the overall GC‑MS Software market size and underpin the GC‑MS Software segmentation framework used by analysts.